Brodimoprim
Clinical data | |
---|---|
ATC code | J01EA02 (WHO) |
Identifiers | |
| |
CAS Number | 56518-41-3 |
PubChem (CID) | 68760 |
ChemSpider | 62004 |
UNII | V1YC7T6LLI |
KEGG | D07238 |
ChEBI | CHEBI:131726 |
ChEMBL | CHEMBL31891 |
ECHA InfoCard | 100.054.745 |
Chemical and physical data | |
Formula | C13H15BrN4O2 |
Molar mass | 339.188 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
This article is issued from Wikipedia - version of the 4/15/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.